Yen, Chia-Hung <br/><br/>
Sildenafil limits monocrotaline-induced pulmonary hypertension in rats through suppression of pulmonary vascular remodeling.  [electronic resource] 

 -  Journal of cardiovascular pharmacology  Jun 2010 
 - 574-84 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1533-4023 
<br/><br/><label>Standard No.: </label>10.1097/FJC.0b013e3181d9f5f4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Arterioles--drug effects<br/>Blood Vessels--metabolism<br/>Caspase 3--metabolism<br/>Connexin 43--metabolism<br/>Hypertension--metabolism<br/>Hypertension, Pulmonary--chemically induced<br/>Lung--blood supply<br/>Male<br/>Monocrotaline--adverse effects<br/>Nitric Oxide Synthase Type III--metabolism<br/>Piperazines<br/>Purines<br/>Random Allocation<br/>Rats<br/>Rats, Sprague-Dawley<br/>Sildenafil Citrate<br/>Sulfones<br/>Tumor Necrosis Factor-alpha--adverse effects<br/>Ventricular Myosins--adverse effects